2017 annual financial data
Neuphoria Therapeutics 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was -5.3%.
Operating income was -13,844,642 USD and net income was -5,186,744 USD.
Operating cash flow was -1,439,842 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,145,815 USD
- Operating income
- -13,844,642 USD
- Net income
- -5,186,744 USD
- Operating cash flow
- -1,439,842 USD